GPT Healthcare Future Growth
Future criteria checks 5/6
GPT Healthcare is forecast to grow earnings and revenue by 21% and 16.5% per annum respectively. EPS is expected to grow by 20.6% per annum. Return on equity is forecast to be 24.7% in 3 years.
Key information
21.0%
Earnings growth rate
20.6%
EPS growth rate
Healthcare earnings growth | 27.3% |
Revenue growth rate | 16.5% |
Future return on equity | 24.7% |
Analyst coverage | Low |
Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 5,954 | 830 | 566 | 1,166 | 1 |
3/31/2026 | 5,117 | 702 | 886 | 986 | 1 |
3/31/2025 | 4,281 | 564 | 210 | 810 | 1 |
9/30/2024 | 3,995 | 491 | 377 | 595 | N/A |
6/30/2024 | 4,018 | 478 | N/A | N/A | N/A |
3/31/2024 | 4,002 | 478 | 494 | 688 | N/A |
12/31/2023 | 3,969 | 486 | N/A | N/A | N/A |
9/30/2023 | 3,932 | 455 | 618 | 776 | N/A |
6/30/2023 | 3,748 | 413 | 607 | 732 | N/A |
3/31/2023 | 3,610 | 390 | 565 | 664 | N/A |
6/30/2022 | 3,297 | 332 | 477 | 558 | N/A |
3/31/2022 | 3,374 | 417 | 587 | 660 | N/A |
3/31/2021 | 2,428 | 211 | 369 | 439 | N/A |
3/31/2020 | 2,118 | 110 | -56 | 415 | N/A |
3/31/2019 | 1,719 | 150 | 71 | 324 | N/A |
3/31/2018 | 1,462 | 76 | N/A | 223 | N/A |
9/30/2017 | 1,360 | 219 | N/A | N/A | N/A |
6/30/2017 | 1,344 | 127 | N/A | N/A | N/A |
3/31/2017 | 1,328 | 35 | N/A | N/A | N/A |
3/31/2016 | 1,165 | 16 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 544131's forecast earnings growth (21% per year) is above the savings rate (6.7%).
Earnings vs Market: 544131's earnings (21% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: 544131's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 544131's revenue (16.5% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 544131's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 544131's Return on Equity is forecast to be high in 3 years time (24.7%)